Data / Form D filings / Neuralink Corp.
Neuralink Corp.: Form D filings
Neuralink Corp., a biotechnology company in Fremont, CA, filed 6 Form D notices with the SEC between 2017 and 2025. The latest, on June 12, 2025, reports $649 million sold of a $649 million offering to 49 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7400 PASEO PADRE PARKWAY, Fremont, CA, 94555
- Phone
- (650) 342-9600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708503
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $649,000,093 | $649,000,093 | 49 | May 30, 2025 | sec.gov | |
| Nov 22, 2023 | Amendment | $323,241,676 | $323,241,676 | 32 | Aug 4, 2023 | sec.gov | |
| Aug 8, 2023 | New notice | $280,274,981 | $280,274,981 | 24 | Aug 4, 2023 | sec.gov | |
| Aug 4, 2021 | New notice | $205,899,985 | $205,899,985 | 32 | Jul 23, 2021 | sec.gov | |
| May 10, 2019 | New notice | $51,312,497 | $39,312,497 | $12,000,000 | 7 | Apr 26, 2019 | sec.gov |
| Aug 25, 2017 | New notice | $100,155,000 | $26,958,000 | $73,197,000 | 12 | Aug 15, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JARED BIRCHALL | Executive Officer, Director | |
| ELON MUSK | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Neuralink Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.